Company intelligence / Profile preview

Medical Microinstruments

Ownership: Private
Employees: ~190
Development stage: Commercial

Overview

The Symani Surgical System enables surgeons to perform complex microsurgical and supermicrosurgical procedures with enhanced precision using the world’s smallest wristed microinstruments. The system offers motion scaling and tremor reduction, expanding treatment options for patients requiring delicate reconstructive surgeries. It has received CE marking in Europe and FDA authorization for use in the U.S., though commercial availability may vary by region

Therapeutic areas: ImmunologyOncologyOphthalmologyOther
Modalities: Device
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Symani Surgical System

Commercial

Indications: Head and neck cancer, Lymphedema, Breast cancer, Trauma

Partnerships

Salesforce (ServiceMax Asset 360 integration)

Beyond the preview

Go deeper on Medical Microinstruments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medical Microinstruments.

Explore the full profile